{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:45:42Z","timestamp":1784828742390,"version":"3.55.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the 100th Anniversary Chulalongkorn University Fund"},{"name":"Thailand Science Research and Innovation Fund of Chulalongkorn University","award":["CU_FRB65_hea (81)_176_37_06"],"award-info":[{"award-number":["CU_FRB65_hea (81)_176_37_06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-77442-2","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:07:29Z","timestamp":1730297249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The CRISPR-dCas9 interference system suppresses inhA gene expression in Mycobacterium smegmatis"],"prefix":"10.1038","volume":"14","author":[{"given":"Nuntita","family":"Singpanomchai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panan","family":"Ratthawongjirakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"77442_CR1","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cell.2017.11.032","volume":"172","author":"F Hille","year":"2018","unstructured":"Hille, F. et al. The Biology of CRISPR-Cas: Backward and forward. Cell 172, 1239\u20131259 (2018).","journal-title":"Cell"},{"key":"77442_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","volume":"45","author":"D Bhaya","year":"2011","unstructured":"Bhaya, D., Davison, M. & Barrangou, R. CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu. Rev. Genet. 45, 273\u2013297 (2011).","journal-title":"Annu. Rev. Genet."},{"key":"77442_CR3","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou, R. et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 315, 1709\u20131712 (2007).","journal-title":"Science"},{"key":"77442_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science. 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"77442_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature09523","volume":"468","author":"JE Garneau","year":"2010","unstructured":"Garneau, J. E. et al. The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. 468, 67\u201371 (2010).","journal-title":"Nature"},{"key":"77442_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-biochem-060815-014607","volume":"85","author":"H Wang","year":"2016","unstructured":"Wang, H., Russa, L. M. & Qi, L. S. CRISPR\/Cas9 in genome editing and beyond. Annu. Rev. Biochem. 85, 227\u2013264 (2016).","journal-title":"Annu. Rev. Biochem."},{"key":"77442_CR7","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.3390\/ijms22073327","volume":"22","author":"S Nidhi","year":"2021","unstructured":"Nidhi, S. et al. Novel CRISPR-Cas systems: an updated review of the current achievements, applications, and future research perspectives. Int. J. Mol. Sci. 22, 3327 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"77442_CR8","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2013.02.022","volume":"152","author":"LS Qi","year":"2013","unstructured":"Qi, L. S. et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell. 152, 1173\u20131183 (2013).","journal-title":"Cell"},{"key":"77442_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1134\/S0026893322060139","volume":"56","author":"NI Nadolinskaia","year":"2022","unstructured":"Nadolinskaia, N. I. & Goncharenko, A. V. CRISPR interference in regulation of bacterial gene gxpression. Mol. Bio. 56, 823\u2013829 (2022).","journal-title":"Mol. Bio"},{"key":"77442_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.29074\/ascls.30.4.207","volume":"30","author":"K Wang","year":"2017","unstructured":"Wang, K. & Nicholaou, M. Suppression of antimicrobial resistance in MRSA using CRISPR-dCas9. Am. Soc. Clin. Lab. Sci. 30, 207\u2013213 (2017).","journal-title":"Am. Soc. Clin. Lab. Sci."},{"key":"77442_CR11","doi-asserted-by":"publisher","unstructured":"Li, Q. et al. Engineering a CRISPR interference system to repress a class 1 integron in Escherichia coli. Antimicrob. Agents Chemother. 4 https:\/\/doi.org\/10.1128\/AAC.01789-19 (2020).","DOI":"10.1128\/AAC.01789-19"},{"key":"77442_CR12","unstructured":"WHO. Global tuberculosis report 2023. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023\/ (2024)."},{"key":"77442_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2013.11.011","volume":"21","author":"H Marrakchi","year":"2014","unstructured":"Marrakchi, H., Lan\u00e9elle, M. A. & Daff\u00e9, M. Mycolic acids: structures, biosynthesis, and beyond. Chem. Biol. 21, 67\u201385 (2014).","journal-title":"Chem. Biol."},{"key":"77442_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.4103\/ijmy.ijmy_69_19","volume":"8","author":"N Sharma","year":"2019","unstructured":"Sharma, N. et al. Expression of mycolic acid in response to stress and association with differential clinical manifestations of tuberculosis. Int. J. Mycobact. 8, 237\u2013243 (2019).","journal-title":"Int. J. Mycobact."},{"key":"77442_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/2049-632X.12110","volume":"70","author":"PC Sequeira","year":"2014","unstructured":"Sequeira, P. C., Senaratne, R. H. & Riley, L. W. Inhibition of toll-like receptor 2 (TLR-2)-mediated response in human alveolar epithelial cells by mycolic acids and Mycobacterium tuberculosis mce1 operon mutant. Pathogens Disease. 70, 132\u2013140 (2014).","journal-title":"Pathogens Disease"},{"key":"77442_CR16","doi-asserted-by":"publisher","first-page":"2150449","DOI":"10.1080\/21505594.2022.2150449","volume":"14","author":"KC Rahlwes","year":"2023","unstructured":"Rahlwes, K. C., Dias, B. R. S., Campos, P. C., Alvarez-Arguedas, S. & Shiloh, M. U. Pathogenicity and virulence of Mycobacterium tuberculosis. Virulence. 14, 2150449 (2023).","journal-title":"Virulence"},{"key":"77442_CR17","doi-asserted-by":"publisher","first-page":"756986","DOI":"10.1100\/tsw.2008.99","volume":"8","author":"MVN de Souza","year":"2008","unstructured":"de Souza, M. V. N. et al. Synthesis and biological aspects of mycolic acids: an important target against Mycobacterium tuberculosis. Sci. World J. 8, 756986 (2008).","journal-title":"Sci. World J."},{"key":"77442_CR18","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.3390\/app10072278","volume":"10","author":"C Vilch\u00e8ze","year":"2020","unstructured":"Vilch\u00e8ze, C. Mycobacterial cell wall: a source of successful targets for old and new drugs. Appl. Sci. 10, 2278 (2020).","journal-title":"Appl. Sci."},{"key":"77442_CR19","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.3390\/ijms21113985","volume":"21","author":"A Ly","year":"2020","unstructured":"Ly, A. & Liu, J. Mycobacterial virulence factors: surface-exposed lipids and secreted proteins. Int. J. Mol. Sci. 21, 3985 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"77442_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/CMR.18.1.81-101.2005","volume":"18","author":"K Takayama","year":"2005","unstructured":"Takayama, K., Wang, C. & Besra, G. S. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis. Clin. Microbiol. Rev. 18, 81\u2013101 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"77442_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41564-022-01139-3","volume":"7","author":"de Carvalho","year":"2022","unstructured":"de Carvalho L.P.S. gene\u2013drug potency screening in M. Tuberculosis. Nat. Microbiol. 7, 743\u2013744 (2022).","journal-title":"Nat. Microbiol."},{"key":"77442_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41564-022-01130-y","volume":"7","author":"S Li","year":"2022","unstructured":"Li, S. et al. CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis. Nat. Microbiol. 7, 766\u2013779 (2022).","journal-title":"Nat. Microbiol."},{"key":"77442_CR23","doi-asserted-by":"publisher","unstructured":"Faulkner, V. et al. Re-sensitization of Mycobacterium smegmatis to rifampicin using CRISPR interference demonstrates its utility for the study of non-essential drug resistance traits. Front. Microbiol. 11 https:\/\/doi.org\/10.3389\/fmicb.2020.619427 (2021).","DOI":"10.3389\/fmicb.2020.619427"},{"key":"77442_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/mmi.14790","volume":"116","author":"MB McNeil","year":"2021","unstructured":"McNeil, M. B., Keighley, L. M., Cook, J. R., Cheung, C. & Cook, G. M. CRISPR interference identifies vulnerable cellular pathways with bactericidal phenotypes in Mycobacterium tuberculosis. Mol. Microb. 116, 1033\u20131043 (2021).","journal-title":"Mol. Microb."},{"key":"77442_CR25","doi-asserted-by":"publisher","unstructured":"Silveiro, C. et al. CRISPRi-mediated characterization of novel anti-tuberculosis targets: mycobacterial peptidoglycan modifications promote beta-lactam resistance and intracellular survival. Front. Cell. Infect. Microbiol. 13 https:\/\/doi.org\/10.3389\/fcimb.2023.1089911 (2023).","DOI":"10.3389\/fcimb.2023.1089911"},{"key":"77442_CR26","doi-asserted-by":"publisher","first-page":"e00337","DOI":"10.1128\/jb.00337-22","volume":"205","author":"IL Sparks","year":"2023","unstructured":"Sparks, I. L., Derbyshire, K. M., Jacobs, W. R. & Morita, Y. S. Mycobacterium smegmatisVanguardnguard of mycobacterial research. J. Bacteriol. 205, e00337\u2013e00322. https:\/\/doi.org\/10.1128\/jb.00337-22 (2023).","journal-title":"J. Bacteriol."},{"key":"77442_CR27","doi-asserted-by":"publisher","unstructured":"Singh, A. K. & Reyrat, J. M. Laboratory maintenance of Mycobacterium smegmatis. Curr. Protoc. Microbiol. Chapter 10, Unit 10C.1. https:\/\/doi.org\/10.1002\/9780471729259.mc10c01s14 (2009).","DOI":"10.1002\/9780471729259.mc10c01s14"},{"key":"77442_CR28","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","volume":"46","author":"JC Palomino","year":"2002","unstructured":"Palomino, J. C. et al. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46, 2720\u20132722 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"77442_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/bs.pmbts.2021.01.007","volume":"180","author":"S Ghavami","year":"2021","unstructured":"Ghavami, S. & Pandi, A. CRISPR interference and its applications. Prog Mol. Biol. Transl Sci. 180, 123\u2013140 (2021).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"77442_CR30","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.3390\/ijms21072329","volume":"21","author":"CF Peddle","year":"2020","unstructured":"Peddle, C. F., Fry, L. E., McClements, M. E. & MacLaren, R. E. CRISPR interference\u2013potential application in retinal disease. Int. J. Mol. Sci. 21, 2329 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"77442_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3390\/antibiotics13060483","volume":"13","author":"Y Yuliani","year":"2024","unstructured":"Yuliani, Y. et al. CRISPR interference-mediated silencing of the mmpL3 gene in Mycobacterium smegmatis and its impact on antimicrobial susceptibility. Antibiotics. 13, 483 (2024).","journal-title":"Antibiotics"},{"key":"77442_CR32","doi-asserted-by":"publisher","unstructured":"Choudhary, E., Sharma, R., Kumar, Y. & Agarwal, N. Conditional silencing by CRISPRi reveals the role of DNA gyrase in formation of drug-tolerant persister population in Mycobacterium tuberculosis. Front. Cell. Infect. Microbiol. 9 https:\/\/doi.org\/10.3389\/fcimb.2019.00070 (2019).","DOI":"10.3389\/fcimb.2019.00070"},{"key":"77442_CR33","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"XH Zhang","year":"2015","unstructured":"Zhang, X. H., Tee, L. Y., Wang, X. G., Huang, Q. S. & Yang, S. H. Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol. Ther. Nucleic Acids. 4, e264. https:\/\/doi.org\/10.1038\/mtna.2015.37 (2015).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"77442_CR34","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"JP Concordet","year":"2018","unstructured":"Concordet, J. P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242\u2013W245. https:\/\/doi.org\/10.1093\/nar\/gky354 (2018).","journal-title":"Nucleic Acids Res."},{"key":"77442_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1089\/mdr.2021.0424","volume":"29","author":"JT Williams","year":"2023","unstructured":"Williams, J. T. & Abramovitch, R. B. Molecular mechanisms of MmpL3 function and inhibition. Microb. Drug Resist. 29, 190\u2013212 (2023).","journal-title":"Microb. Drug Resist."},{"key":"77442_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-0716-1460-0_16","volume-title":"in Mycobacteria Protocols","author":"AI Wong","year":"2021","unstructured":"Wong, A. I. & Rock, J. M. in In Mycobacteria Protocols. 343\u2013364 (eds Tanya, P. & Anuradha, K.) (Springer US, 2021)."},{"key":"77442_CR37","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1093\/nar\/gni086","volume":"33","author":"A Rodr\u00edguez-Garc\u00eda","year":"2005","unstructured":"Rodr\u00edguez-Garc\u00eda, A., Combes, P., P\u00e9rez-Redondo, R., Smith, M. C. A. & Smith, M. C. M. Natural and synthetic tetracycline-inducible promoters for use in the antibiotic-producing bacteria Streptomyces. Nucleic Acids Res. 33, e87\u2013e87. https:\/\/doi.org\/10.1093\/nar\/gni086 (2005).","journal-title":"Nucleic Acids Res."},{"key":"77442_CR38","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3389\/fmicb.2015.00812","volume":"6","author":"JC Evans","year":"2015","unstructured":"Evans, J. C. & Mizrahi, V. The application of tetracycline regulated gene expression systems in the validation of novel drug targets in Mycobacterium tuberculosis. Front. Microbiol. 6, 812 (2015).","journal-title":"Front. Microbiol."},{"key":"77442_CR39","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41467-018-04209-5","volume":"9","author":"L Cui","year":"2018","unstructured":"Cui, L. et al. A CRISPRi screen in E. Coli reveals sequence-specific toxicity of dCas9. Nat. Commun. 9, 1912 (2018).","journal-title":"Nat. Commun."},{"key":"77442_CR40","doi-asserted-by":"publisher","unstructured":"Rishi, H. S. et al. Systematic genome-wide querying of coding and non-coding functional elements in E. coli using CRISPRi. Preprint at https:\/\/www.biorxiv.org\/content\/ (2020). https:\/\/doi.org\/10.1101\/2020.03.04.975888v1","DOI":"10.1101\/2020.03.04.975888v1"},{"key":"77442_CR41","doi-asserted-by":"publisher","unstructured":"Guzzo, M., Castro, L. K., Reisch, C. R., Guo, M. S. & Laub, M. T. A CRISPR interference system for efficient and rapid gene knockdown in Caulobacter crescentus. mBio. 11; (2020). https:\/\/doi.org\/10.1128\/mbio.02415-19","DOI":"10.1128\/mbio.02415-19"},{"key":"77442_CR42","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.cell.2016.05.003","volume":"165","author":"JM Peters","year":"2016","unstructured":"Peters, J. M. et al. A comprehensive, CRISPR-based functional analysis of essential genes in bacteria. Cell 165, 1493\u20131506 (2016).","journal-title":"Cell"},{"key":"77442_CR43","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell. 159, 647\u2013661 (2014).","journal-title":"Cell"},{"key":"77442_CR44","doi-asserted-by":"publisher","first-page":"16274","DOI":"10.1038\/nmicrobiol.2016.274","volume":"2","author":"JM Rock","year":"2017","unstructured":"Rock, J. M. et al. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat. Microbiol. 2, 16274 (2017).","journal-title":"Nat. Microbiol."},{"key":"77442_CR45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.15252\/msb.20167449","volume":"13","author":"X Liu","year":"2017","unstructured":"Liu, X. et al. High-throughput CRISPRi phenotyping identifies new essential genes in Streptococcus pneumoniae. Mol. Syst. Biol. 13, 931 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"77442_CR46","doi-asserted-by":"publisher","unstructured":"Nguyen, T. Q. et al. CRISPR interference-based inhibition of MAB_0055c expression alters drug sensitivity in Mycobacterium abscessus. Microbiol. Spectr. 11 https:\/\/doi.org\/10.1128\/spectrum.00631-23 (2023).","DOI":"10.1128\/spectrum.00631-23"},{"key":"77442_CR47","doi-asserted-by":"publisher","unstructured":"Kurepina, N. et al. CRISPR inhibition of essential peptidoglycan biosynthesis genes in Mycobacterium abscessus and its impact on \u03b2-lactam susceptibility. Antimicrob. Agents Chemother. 66 https:\/\/doi.org\/10.1128\/aac.00093-22 (2022).","DOI":"10.1128\/aac.00093-22"},{"key":"77442_CR48","doi-asserted-by":"publisher","unstructured":"Singh, A. K. et al. Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system. Nucleic Acids Res. 44 https:\/\/doi.org\/10.1093\/nar\/gkw625 (2016).","DOI":"10.1093\/nar\/gkw625"},{"key":"77442_CR49","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1128\/JB.182.14.4059-4067.2000","volume":"182","author":"C Vilch\u00e8ze","year":"2000","unstructured":"Vilch\u00e8ze, C. et al. Inactivation of the inha-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatis. J. Bacteriol. 182, 4059\u20134067 (2000).","journal-title":"J. Bacteriol."},{"key":"77442_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-43676-0_18-1","volume-title":"Biogenesis of fatty acids, lipids and membranes (ed","author":"M Daff\u00e9","year":"2017","unstructured":"Daff\u00e9, M., Qu\u00e9mard, A. & Marrakchi, H. Biogenesis of Fatty Acids, Lipids and Membranes (edGeiger, O.) 1\u201336 (Springer International Publishing, 2017)."},{"key":"77442_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","volume":"45","author":"AN Unissa","year":"2016","unstructured":"Unissa, A. N., Subbian, S., Hanna, L. E. & Selvakumar, N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect. Genet. Evol. 45, 474\u2013492 (2016).","journal-title":"Infect. Genet. Evol."},{"key":"77442_CR52","doi-asserted-by":"publisher","first-page":"7596","DOI":"10.1128\/JB.187.22.7596-7606.2005","volume":"187","author":"A Bhatt","year":"2005","unstructured":"Bhatt, A., Kremer, L., Dai, A. Z., Sacchettini, J. C. & Jacobs, W. R. Jr. Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J. Bacteriol. 187, 7596\u20137606 (2005).","journal-title":"J. Bacteriol."},{"key":"77442_CR53","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.4014\/jmb.1705.05013","volume":"27","author":"S Kim","year":"2017","unstructured":"Kim, S. et al. In vitro effect of DFC-2 on mycolic acid biosynthesis in Mycobacterium tuberculosis. J. Microbiol. Biotechnol. 27, 1932\u20131941 (2017).","journal-title":"J. Microbiol. Biotechnol."},{"key":"77442_CR54","doi-asserted-by":"publisher","unstructured":"Samukawa, N. et al. An efficient CRISPR interference-based prediction method for synergistic\/additive effects of novel combinations of anti-tuberculosis drugs. Microbiology\u00a0168 https:\/\/doi.org\/10.1099\/mic.0.001285 (2022).","DOI":"10.1099\/mic.0.001285"},{"key":"77442_CR55","doi-asserted-by":"publisher","unstructured":"de Wet, T. J., Winkler, K. R., Mhlanga, M., Mizrahi, V. & Warner, D. F. Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes. Elife 9, https:\/\/doi.org\/10.7554\/eLife.60083 (2020).","DOI":"10.7554\/eLife.60083"},{"key":"77442_CR56","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.cell.2005.11.011","volume":"123","author":"MM Zambrano","year":"2005","unstructured":"Zambrano, M. M. & Kolter, R. Mycobacterial biofilms: a greasy way to hold it together. Cell 123, 762\u2013764 (2005).","journal-title":"Cell"},{"key":"77442_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1365-2958.2008.06274.x","volume":"69","author":"AK Ojha","year":"2008","unstructured":"Ojha, A. K. et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol. Microbiol. 69, 164\u2013174 (2008).","journal-title":"Mol. Microbiol."},{"key":"77442_CR58","unstructured":"Addgene Sequence Analyzer: PLJR962 sequencing result: primers. https:\/\/www.addgene.org\/browse\/sequence\/222096\/\u00a0(2017)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77442-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77442-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T14:11:00Z","timestamp":1730297460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-77442-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["77442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-77442-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26116"}}